[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_1920",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_1920"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB11560"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "zurampic is indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone s ee clinical studies 14 zurampic is a urat1 inhibitor indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone 1 limitations of use zurampic is not recommended for the treatment of asymptomatic hyperuricemia 1 1 zurampic should not be used as monotherapy 1 1 5 1 zurampic is not recommended for the treatment of asymptomatic hyperuricemia zurampic should not be used as monotherapy see warnings and precautions 5 1"
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/TreatmentIndication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB11560",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-06-12T12:52:49.021+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "TCktFV5r6rSCbj7Zv1K4VQXaDLk9+3W9CEgmJZqsbGrzf6H5nlQxCfPWrGn1f38drns6pgwm3d7m8OXU/8zOk1+SpSTBr6Gdl1nACEq7QSnCi60IyjVLySEkHmH4bU4tb4kdapUVyA9Wk81iRxMWXRSmdeZRIQxEz/TzPTuTbm8="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAvw8F2rV_yfYooruBvDAlNEOhbPf_t199nf4lj22XFXE#pubinfo"
} ]